Gastrodin Inhibits Store-Operated Ca2+ Entry and Alleviates Cardiac Hypertrophy

• Prif Awduron: Xiaoqiang Yao (Awdur), Changbo Zheng (Awdur), Chun-Yin Lo (Awdur), Zhaoyue Meng (Awdur), Zhichao Li (Awdur), Mingkui Zhong (Awdur), Peng Zhang (Awdur), Jun Lu (Awdur), Zhaoxiang Yang (Awdur), Fuman Yan (Awdur), Yunting Zhang (Awdur), Yu Huang (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: Frontiers Media S.A., 2017-04-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

Cardiac hypertrophy is a major risk factor for heart failure, which are among the leading causes of human death. Gastrodin is a small molecule that has been used clinically to treat neurological and vascular diseases for many years without safety issues. In the present study, we examined protective...